Healthcare provider profile · identity verified

Maged Ghoprial, M.D

Family Practice · MOLINE, IL · NPI 1104212265

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	323	89
Amlodipine Besylate	Amlodipine Besylate	272	69
Gabapentin	Gabapentin	249	55
Rosuvastatin Calcium	Rosuvastatin Calcium	199	65
Losartan Potassium	Losartan Potassium	193	54
Metformin Hcl Er	Metformin Hcl	178	55
Lisinopril	Lisinopril	152	45
Jardiance	Empagliflozin	151	37
Albuterol Sulfate Hfa	Albuterol Sulfate	142	48
Ozempic	Semaglutide	121	23
Fluticasone Propionate	Fluticasone Propionate	111	44
Famotidine	Famotidine	102	19
Trazodone Hcl	Trazodone Hcl	102	35
Levothyroxine Sodium	Levothyroxine Sodium	97	23
Spironolactone	Spironolactone	95	26
Tramadol Hcl	Tramadol Hcl	92	39
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	16
Metformin Hcl	Metformin Hcl	88	26
Tamsulosin Hcl	Tamsulosin Hcl	88	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	87	25
Metoprolol Succinate	Metoprolol Succinate	86	22
Duloxetine Hcl	Duloxetine Hcl	84	22
Baclofen	Baclofen	81	19
Alprazolam	Alprazolam	73	28
Sertraline Hcl	Sertraline Hcl	72	18
Bupropion Xl	Bupropion Hcl	69	21
Allopurinol	Allopurinol	68	16
Omeprazole	Omeprazole	68	20
Carvedilol	Carvedilol	65	18
Montelukast Sodium	Montelukast Sodium	64	23
Pantoprazole Sodium	Pantoprazole Sodium	64	16
Varenicline Tartrate	Varenicline Tartrate	63	suppressed
Furosemide	Furosemide	60	17
Pravastatin Sodium	Pravastatin Sodium	60	suppressed
Xarelto	Rivaroxaban	56	suppressed
Alendronate Sodium	Alendronate Sodium	46	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	45	11
Eliquis	Apixaban	45	11
Januvia	Sitagliptin Phosphate	43	suppressed
Potassium Chloride	Potassium Chloride	43	11
Tresiba Flextouch U-100	Insulin Degludec	42	12
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Spiriva Respimat	Tiotropium Bromide	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	12
Mounjaro	Tirzepatide	37	suppressed
Myrbetriq	Mirabegron	35	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	11
Hydroxyzine Hcl	Hydroxyzine Hcl	34	12
Ondansetron Odt	Ondansetron	34	suppressed
Azithromycin	Azithromycin	33	31
Doxycycline Hyclate	Doxycycline Hyclate	33	26
Meloxicam	Meloxicam	33	14
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Prednisone	Prednisone	32	29
Pregabalin	Pregabalin	31	suppressed
Celecoxib	Celecoxib	29	suppressed
Eplerenone	Eplerenone	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	11
Belsomra	Suvorexant	27	suppressed
Testosterone Cypionate	Testosterone Cypionate	27	suppressed
Chlorzoxazone	Chlorzoxazone	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Simvastatin	Simvastatin	26	11
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Clonazepam	Clonazepam	21	14
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Levofloxacin	Levofloxacin	20	17
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Ketoconazole	Ketoconazole	19	13
Lorazepam	Lorazepam	19	16
Mupirocin	Mupirocin	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Temazepam	Temazepam	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	15	suppressed
Methylprednisolone	Methylprednisolone	15	13
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cephalexin	Cephalexin	13	12
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Dayvigo	Lemborexant	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Linzess	Linaclotide	11	suppressed
Nystatin	Nystatin	11	suppressed
Qulipta	Atogepant	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error